Methemoglobinemia is a blood disorder that occurs when too little oxygen is delivered to the cells of the body. There are two kinds of methemoglobinemia — congenital and acquired. Methemoglobinemia ...

Methemoglobinemia is a blood disorder in which too little oxygen is delivered to your cells. An individual may be born with it, or it may be caused by exposure to certain medicines, chemicals, or ...

Acquired methemoglobinemia is a rare disorder affecting the oxygen-carrying capacity of hemoglobin that is caused by exposure to certain chemicals or medications. Outbreaks of methemoglobinemia are ...

Persons with recessively transmitted methemoglobinemia have slate-gray cyanosis. In general they encounter little difficulty although a small but significant number have mental retardation. In 1956 ...

One-third of infants with persistent pulmonary hypertension of the newborn (PPHN) do not respond to inhaled nitric oxide (iNO). If iNO is not delivered to the pulmonary vasculature because of ...

The history of the Fugates, a family affected by a strange genetic disorder, has resurfaced online this week, leaving many wondering if blue skin is scientifically possible.The Fugates were a family ...

Methemoglobinemia is a congenital or acquired blood disorder caused by an abnormal amount of methemoglobin which is a form of hemoglobin. Hemoglobin is the protein in red blood cells (RBCs) ...

A previously healthy 52-year-old Asian woman presented to the emergency department after a syncopal episode. She appeared grey and cyanotic. At 65% fraction of inspired oxygen, pulse oximetry showed ...

A report published in the New England Journal of Medicine describes the case of a 25-year-old woman who developed methemoglobinemia following the use of topical benzocaine. According to clinicians ...

In James Cameron’s 2009 blockbuster "Avatar," the forest-loving Na’vi have stunning blue skin. But in real life, can people actually have that skin color? Yes, it turns out, and a family living in ...

The sulfone antibiotic dapsone, at prophylactic doses, can be associated with the development of methemoglobinemia and hemolytic anemia in patients with and without glucose-6-phosphate dehydrogenase ...